Daily Aspirin for Heart Attack and Stroke Prevention is Ineffective and Dangerous

http://www.myhousecallmd.com/wp-content/uploads/2010/07/aspirin.jpg

Some folks seem to get away with playing pharmaceutical roulette while more are damaged in one way or another. A few die. The first half of this article will attempt to explain what’s wrong with the aspirin or half aspirin or baby aspirin as a blood thinner, or any prescription blood thinner as well. The second half will provide alternative natural options that are effective without side effects.

Thanks to the publicized campaigns to promote aspirin as a simple protection against heart attacks and strokes, there a many who take the false advice to their unhealthy detriment, which they will often not attribute to aspirin as a cause. (more…)

Science Confirms Turmeric As Effective As 14 Drugs

Activist Post

Turmeric is one the most thoroughly researched plants in existence today. Its medicinal properties and components (primarily curcumin) have been the subject of over 5600 peer-reviewed and published biomedical studies. In fact, our five-year long research project on this sacred plant has revealed over 600 potential preventive and therapeutic applications, as well as 175 distinct beneficial physiological effects. This entire database of 1,585 ncbi-hyperlinked turmeric abstracts can be downloaded as a PDF at our Downloadable Turmeric Document page, and acquired either as a retail item or with 200 GMI-tokens, for those of you who are already are members and receive them automatically each month. (more…)

Pradaxa: Legal Mass Murder!

Description: http://www.secretsofthefed.com/wp-content/uploads/2012/10/deathRx-1.png

A Promising Drug With a Flaw was the name of an article published in the New York Times this past week.

Dr. Bryan A. Cotton, a trauma surgeon in Houston, had not heard much about the new anticlotting drug Pradaxa other than the commercials he had seen during Sunday football games. Then people using Pradaxa started showing up in his emergency room. One man in his 70s fell at home and arrived at the hospital alert and talking. But he rapidly declined. “We pretty much threw the whole kitchen sink at him,” recalled Dr. Cotton, who works at Memorial Hermann-Texas Medical Center. “But he still bled to death on the table.” Unlike warfarin, an older drug, there is no antidote to reverse the blood-thinning effects of Pradaxa. “You feel helpless,” Dr. Cotton said. The drug has contributed to the bleeding deaths of at least eight patients at the hospital. “And that’s a very bad feeling for us.” Pradaxa has become a blockbuster drug in its two years on the market, bringing in more than $1 billion in sales for its maker, the privately held German drug maker Boehringer Ingelheim. (more…)

Omega-3 fatty acids boost blood thinning therapy

Omega-3 fatty acids boost blood thinning therapyAn article published online on May 26, 2011 in Arteriosclerosis, Thrombosis and Vascular Biology reports the discovery of Polish researchers of a benefit for adding the omega-3 polyunsaturated fatty acids (PUFA) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to standard therapy for heart disease patients undergoing percutaneous coronary intervention (coronary angioplasty). (more…)

SerratioPeptidase is a potent anti-inflammatory enzyme

Proteolytic enzymes are specific enzymes that metabolize protein. These enzymes are naturally produced by the human body and other living organisms and help carry out essential functions. Supplementing with these enzymes has shown to have a favorable anti-inflammatory effect on the tissues of the body. A unique enzyme named serratiopeptidase is now emerging as one of the most potent anti-inflammatory supplements. (more…)

FDA admits heart drug doubles risk of death

Regulators with the Food and Drug Administration have warned that Multaq, a cardiac drug Sanofi, has been linked with fatal heart problems in a clinical trial the company recently ended.

In the study involving 3,000 patients, 32 who were taking Multaq died from cardiac-related problems compared with 14 who were taking a placebo. In all, nearly twice as many people suffered heart attacks, strokes and death than those in the placebo control group. (more…)

Dabigatran beats warfarin in VTE

The new findings, presented Sunday at the American Society of Hematology (ASH) 2009 Meeting and published online in the New England Journal of Medicine, come hard on the heels of the RE-LY results, reported by heartwire, showing dabigatran to be superior to warfarin in preventing strokes and peripheral embolic events in patients with atrial fibrillation (AF)  (more…)